Actively Recruiting
Lymph Node Pathologic Grading Strategy
Led by Fudan University · Updated on 2024-12-20
2998
Participants Needed
1
Research Sites
53 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The percentage of high-grade patterns in metastatic LNs (mLNs) that can predict poor outcomes has yet to be determined. Additionally, the potential implications of other histologic patterns in metastatic lymph nodes on patient outcomes warrant further investigation. We conducted a retrospective cohort study to investigate the prognostic value of pathologic pattern in metastatic lymph nodes.
CONDITIONS
Official Title
Lymph Node Pathologic Grading Strategy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with invasive lung adenocarcinoma who underwent surgical resection at Fudan University Shanghai Cancer Center between January 2011 and September 2021
You will not qualify if you...
- Adenocarcinoma in situ, minimally invasive adenocarcinoma, invasive mucinous adenocarcinoma, and other adenocarcinoma variants
- Incomplete data on common driver mutations
- Unavailable pathologic slides
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality, China, 200032
Actively Recruiting
Research Team
Z
Zhu
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here